Absci (ABSI) Revenue Growth (5y) (2025 - 2026)

Absci (ABSI) Revenue Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	65,899.61 Bn	65,899.33 Bn	-
2	Nanobiotix	1,933.82 Bn	1,933.76 Bn	-
3	Akari Therapeutics	1,022.34 Bn	1,022.34 Bn	-
4	BeOne Medicines	472.68 Bn	467.89 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.24 Bn	114.99 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.08 Bn	61.33 Bn	3.31 Bn
7	Belite Bio	62.46 Bn	62.46 Bn	-
8	Argenx Se	55.93 Bn	50.75 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.59 Bn	34.58 Bn	959.66 Mn
10	Absci	1.18 Bn	1.06 Bn	-

Download Data